Treatment and Prophylaxis of Gout Flare in the Clinic: An Office-Based Approach to Gout Management

被引:2
|
作者
Lieberman, Joseph A., III [1 ]
机构
[1] Jefferson Med Coll, Hockessin, DE 19707 USA
关键词
arthritis; gouty; colchicine; gout; hyperuricemia; physicians; primary care; uric acid; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EVIDENCE BASED RECOMMENDATIONS; SERUM URATE; URIC-ACID; DOUBLE-BLIND; STANDING-COMMITTEE; TASK-FORCE; TRIAMCINOLONE ACETONIDE; GASTROINTESTINAL SAFETY; CARDIOVASCULAR-DISEASE;
D O I
10.3810/pgm.2011.11.2505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gout is an often-overlooked and undertreated inflammatory arthritis that is most frequently managed in the primary care office. Its initial clinical presentation may include acute-onset pain that is most typically associated with the big toe (podagra) or knee. Most patients with gout can be successfully treated from the primary care physician's office with little or no need for referral to a rheumatology practice. Prompt recognition, diagnosis, and management can greatly improve the lives of patients with gout. Patient education is important; addressing modifiable risk factors promptly after initial presentation can arrest the development of serious debilitating effects and improve, or occasionally replace, pharmacologic intervention. This article will discuss the epidemiology, pathophysiology, and diagnosis of gout, as well as management of the acute flare and management of chronic gout with urate-lowering therapy, including prophylaxis.
引用
收藏
页码:151 / 165
页数:15
相关论文
共 50 条
  • [1] Pharmacoepidemiology of Gout Treatment in Office-based Outpatient Care from 2009-2016
    Chock, Yu Pei
    Ross, Joseph
    Suter, Lisa
    Rhee, Taeho Greg
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Experience of Using Gout Flare Prophylaxis in the FAST Trial
    Flynn, Robert W. V.
    Jennings, Claudine
    Mackenzie, Isla S.
    Ford, Ian
    Nuki, George
    MacDonald, Thomas M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 421 - 422
  • [3] Gout flare prophylaxis during management of chronic gout with febuxostat, a non-purine selective inhibitor of xanthine oxidase.
    Wortmann, R
    Becker, MA
    Schumacher, HR
    MacDonald, P
    Palo, WA
    Joseph-Ridge, N
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S335 - S336
  • [4] Oral Colchicine (Colcrys®) In the Treatment and Prophylaxis of Gout
    Yang, Lily P. H.
    DRUGS, 2010, 70 (12) : 1603 - 1613
  • [5] Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares
    Choi, Hyo Jin
    Lee, Chan Hee
    Lee, Joo Hyun
    Yoon, Bo Young
    Kim, Hyoun Ah
    Suh, Chang Hee
    Choi, Sang Tae
    Song, Jung Soo
    Joo, Ho Yeon
    Choi, Sung Jae
    Lee, Ji Soo
    Shin, Kee Chul
    Baek, Han Joo
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (04) : 497 - 503
  • [6] Oral Colchicine (Colcrys®)In the Treatment and Prophylaxis of Gout
    Lily P. H. Yang
    Drugs, 2010, 70 : 1603 - 1613
  • [7] My Treatment Approach to Gout
    Aslam, Fawad
    Michet, Clement, Jr.
    MAYO CLINIC PROCEEDINGS, 2017, 92 (08) : 1234 - 1247
  • [8] Buprenorphine maintenance: Office-based treatment with addiction clinic support
    Ortner, R
    Jagsch, R
    Schindler, SD
    Primorac, A
    Fischer, G
    EUROPEAN ADDICTION RESEARCH, 2004, 10 (03) : 105 - 111
  • [9] GOUT FLARE PROPHYLAXIS EVALUATED ACCORDING TO THE 2012 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) GUIDELINES: ANALYSIS FROM THE CORRONA GOUT REGISTRY
    Schlesinger, N.
    Etzel, C. J.
    Greenberg, J. D.
    Kremer, J. M.
    Harrold, L. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 782 - 782
  • [10] Quality of Gout Management in a Rheumatology Clinic Using a Provider-Pharmacist Team-Based Approach
    Michaud, Jessica
    Beatty, Jenna
    ARTHRITIS & RHEUMATOLOGY, 2018, 70